Signed in as:
filler@godaddy.com
Epilepsy affects women uniquely — from the menstrual cycle to pregnancy, contraception, and menopause. Dr. Theochari, an epilepsy specialist, provides expert, woman-centred care for those with neurological conditions in London, including private neurological consultations.

Women with epilepsy face challenges that are distinct from those of men — and they deserve specialist care that recognizes this. Hormonal fluctuations across the menstrual cycle, the interaction between anti-seizure medications and contraception, the complexities of planning and managing pregnancy, and the impact of menopause on seizure control are all areas where women with epilepsy need expert, individualized guidance from an epilepsy specialist. Unfortunately, these issues are not always addressed thoroughly in a general neurology setting. Dr. Theochari has a particular interest in women's epilepsy and provides dedicated, unhurried private neurological consultations that cover all aspects of epilepsy management as it relates to women's health.

New hormones, new challenges
Puberty often marks a change in seizure frequency or pattern. The onset of menstruation can be associated with worsening seizures in some girls — a phenomenon known as catamenial epilepsy. Adolescence is also a critical time to discuss long-term plans for contraception, fertility, and future pregnancy, even if these feel distant.
Anti-seizure medications may also affect bone density over time, and this is an important consideration to address early.
Contraception & seizure control
Choosing the right contraception can be more complex for women with epilepsy, especially when considering the advice of an epilepsy specialist. Some anti-seizure medications (enzyme-inducing ASMs) can significantly reduce the effectiveness of hormonal contraceptives — meaning that methods like the combined pill may not offer reliable protection. Additionally, certain hormonal contraceptives might influence seizure frequency, which is a critical consideration for those with neurological conditions.
Dr. Theochari will conduct a thorough review of your specific medications during private neurological consultations and recommend the safest and most effective contraceptive options for you — a vital discussion that is often overlooked.
The most critical time for specialist input in managing epilepsy is during pregnancy. This area of women's epilepsy requires careful planning and the guidance of an epilepsy specialist. Certain anti-seizure medications — most notably valproate (sodium valproate / Epilim) — pose significant risks to the developing baby and should be avoided during pregnancy unless there are no alternatives available. This is strictly regulated under the UK Valproate Prevent Programme.
With the right preparation and specialist support, including private neurological consultations, the vast majority of women with epilepsy can enjoy healthy pregnancies and have healthy babies. The key is to plan ahead — ideally discussing pregnancy with a healthcare provider at least 6–12 months before trying to conceive.
After the birth, sleep deprivation is a well-known seizure trigger for individuals with neurological conditions like epilepsy, and it needs to be planned for accordingly. Most anti-seizure medications are compatible with breastfeeding, though this should be reviewed individually with an epilepsy specialist. Practical safety advice for caring for a newborn while managing seizure risk is an important part of postpartum care, and private neurological consultations can provide valuable guidance.
A time of change — for seizures too
The hormonal fluctuations of perimenopause can destabilise previously well-controlled epilepsy. Some women experience a significant increase in seizure frequency during this period. Menopause itself, and decisions about hormone replacement therapy (HRT), require careful consideration in the context of epilepsy and current medications. Consulting with an epilepsy specialist can provide valuable insights into managing these changes alongside existing neurological conditions.
Dr. Theochari offers private neurological consultations to help women navigate this transition while keeping their epilepsy as well-managed as possible.
Approximately one in three women with epilepsy notice that their seizures are more likely to occur at certain times of their menstrual cycle. This phenomenon is known as catamenial epilepsy and highlights the impact of sex hormones—particularly oestrogen and progesterone—on seizure threshold. Consulting an epilepsy specialist can provide valuable insights into how these hormonal fluctuations affect neurological conditions. Oestrogen tends to be pro-convulsant, lowering the seizure threshold, while progesterone offers a protective effect. As these hormones fluctuate throughout the cycle, the risk of seizures follows suit, making private neurological consultations essential for tailored management strategies.


This is one of the most important — and most frequently under-discussed — aspects of epilepsy care for women. The interaction between anti-seizure medications and hormonal contraceptives can work in two directions: some ASMs reduce the effectiveness of contraception, and some hormonal methods may affect seizure frequency.
Not affected by any anti-seizure medication. Highly effective and a reliable choice for women on enzyme-inducing ASMs.
Hormonal, but acts locally. Generally considered effective even with enzyme-inducing ASMs — discuss with your specialist.
Effectiveness may be reduced by enzyme-inducing ASMs. Higher-dose options or alternative methods may be needed.
May be less effective with enzyme-inducing ASMs. Specialist review is essential before relying on this method.
Significantly reduced effectiveness with many commonly used ASMs including carbamazepine, phenytoin, topiramate, and others. Not reliable without specialist guidance.
Similarly affected by enzyme-inducing ASMs. These methods may not provide adequate protection without medication review.

Most women with epilepsy go on to have healthy pregnancies and healthy babies. However, careful planning — ideally beginning at least 6–12 months before trying to conceive — significantly improves outcomes for both mother and baby.
Sodium valproate (Epilim, Depakote) carries a significant risk of serious harm to the unborn baby, including physical malformations and neurodevelopmental problems affecting learning and development. It must not be used in pregnancy or in women of childbearing potential unless they are enrolled in the UK Valproate Prevent Programme and using highly effective contraception.
If you are currently taking valproate, please do not stop suddenly — contact Dr. Theochari urgently to review your medication before making any changes.
Review and optimise anti-seizure medication — aiming for seizure freedom on the lowest effective dose of the safest possible drug. Start high-dose folic acid (5mg daily). Discuss risks specific to your medication. Review driving and lifestyle implications.
Inform your epilepsy team as soon as possible. Drug levels may change as the body adapts to pregnancy — closer monitoring is often needed. Early anomaly scan and continued folic acid. Avoid known seizure triggers (sleep deprivation, missed medication)
Regular medication level monitoring. Detailed anomaly scan at 20 weeks. Joint care between epilepsy specialist and obstetrician. Planning for safe delivery — most women with epilepsy can deliver normally. Discussion of postpartum seizure management and breastfeeding.
Sleep deprivation is a major seizure trigger — a plan for shared night care is important. Review medication levels (which often change again after delivery). Practical safety advice for caring for a newborn. Most ASMs are compatible with breastfeeding — this will be reviewed individually.

The perimenopause and menopause transition is a time of significant hormonal change — and for women with epilepsy, this can have a real impact on seizure control that is frequently underappreciated.

It depends on which anti-seizure medication you are taking. Enzyme-inducing ASMs (such as carbamazepine, phenytoin, topiramate, and others) significantly reduce the effectiveness of the combined oral contraceptive pill and some other hormonal methods. Dr. Theochari will review your specific medications and recommend reliable alternatives. Non-hormonal contraception (copper IUD) is effective regardless of medication.
Yes — the vast majority of women with epilepsy have healthy pregnancies and healthy babies. However, careful pre-conception planning is essential. The risks depend greatly on which medication you are taking, and some medications (particularly valproate) must be reviewed urgently before pregnancy is considered. Ideally, speak to Dr. Theochari at least 6–12 months before you plan to conceive.
Most anti-seizure medications are considered compatible with breastfeeding, though this varies between drugs and requires individual assessment. Dr. Theochari will review your specific medication and discuss the available evidence so you can make an informed decision about whether to breastfeed.
Yes — this is called catamenial epilepsy and affects around one in three women with epilepsy. It is caused by hormonal fluctuations across the menstrual cycle affecting the brain's susceptibility to seizures. Keeping a seizure diary alongside your cycle is the first step to identifying this pattern, after which targeted treatments can be considered.
It can do, for some women. Perimenopause in particular — with its erratic hormonal fluctuations — is often the most disruptive period. Some women experience increased seizure frequency; others notice no change. Dr. Theochari can help manage this transition and advise on whether HRT is appropriate for you
Epilepsy affects women uniquely — from the menstrual cycle to pregnancy, contraception, and menopause. Dr. Theochari, an epilepsy specialist, provides expert, woman-centred care for those with neurological conditions in London, including private neurological consultations.